TMDX Valuation

Transmedics Group Inc

Add to Watchlist

Advanced Chart

106.790

-3.18(-2.892%)1D

Overview
Forecast
Valuation
Earnings

TMDX Relative Valuation

TMDX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TMDX is overvalued; if below, it's undervalued.

Historical Valuation

Transmedics Group Inc (TMDX) is now in the Fair zone, suggesting that its current forward PS ratio of 5.86 is considered Fairly compared with the five-year average of -13.99. The fair price of Transmedics Group Inc (TMDX) is between 90.34 to 264.57 according to relative valuation methord.

Relative Value

Fair Zone

90.34-264.57

Current Price：106.79

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

13.97

P/B

Median3y

16.72

Median5y

13.28

-1.77

FCF Yield

Median3y

-3.94

Median5y

-4.50

Competitors Valuation Multiple

The average P/S ratio for TMDX's competitors is 4.14, providing a benchmark for relative valuation. Transmedics Group Inc Corp (TMDX) exhibits a P/S ratio of 5.86, which is 41.57% above the industry average. Given its robust revenue growth of 48.21%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

TMDX.O

Transmedics Group Inc

5.86

Average P/S: 4.14

48.21%